However, the association of NAFLD and hepatic expression of SARS‐CoV‐2 critical entry proteins, such as ACE2 and TMPRSS2, a host cell serine protease which cleaves the SARS‐CoV‐2 spike protein and mediates fusion of host cellular and viral membranes, are controversial. The gene discussed is ACE2; the disease is metabolic dysfunction-associated steatotic liver disease.